Trastorno obsesivo compulsivo

1. Ruscio AM, Stein DJ, Chiu WT, Kessler RC. The epidemiology of obsessive compulsive disorder in the National Comorbidity Survey Replication. Mol Psychiatry 2010; 15: 53-63.
2. Karno M, Golding JM, Sorenson SB, Burnam MA. The epidemiology of obsessive-compulsive disorder in five US communities. Arch Gen Psychiatry 1988; 45:1094-9.
3. Ayuso-Mateos J. Global burden of obsessive-compulsive disorder in the year 2000. Geneva: World Health Organization, 2006.
4. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Washington, DC: American Psychiatric Association, 2013.
5. Greenberg D, Witztum E. The influence of cultural factors on obsessive compulsive disorder: religious symptoms in a religious society. Isr J Psychiatry Relat Sci 1994; 31:211-20.
6. Fontenelle LF, Mendlowicz MV, Marques C, Versiani M. Trans-cultural aspects of obsessive-compulsive disorder: a description of a Brazilian sample and a systematic review of international clinical studies. J Psychiatr Res 2004; 38:403-11.
7. Geller DA, Biederman J, Faraone S, et al. Developmental aspects of obsessive compulsive disorder: findings in children, adolescents, and adults. J Nerv Ment Dis 2001; 189:471-7.
8. Geller DA. Obsessive-compulsive and spectrum disorders in children and adolescents. Psychiatr Clin North Am 2006; 29:353-70.
9. Narayanaswamy JC, Viswanath B, Veshnal Cherian A, Bada Math S, Kandavel T, Janardhan Reddy YC. Impact of age of onset of illness on clinical phenotype in OCD. Psychiatry Res 2012; 200:554-9.
10. Grant JE, Mancebo MC, Pinto A, Williams KA, Eisen JL, Rasmussen SA. Late onset obsessive compulsive disorder: clinical characteristics and psychiatric comorbidity. Psychiatry Res 2007; 152:21-7.
11. Kalra SK, Swedo SE. Children with obsessive-compulsive disorder: are they just “little adults”? J Clin Invest 2009; 119:737-46.
12. van Grootheest DS, Cath DC, Beekman AT, Boomsma DI. Twin studies on obsessive-compulsive disorder: a review. Twin Res Hum Genet 2005; 8:450-8.
13. Stewart SE, Yu D, Scharf JM, et al. Genome-wide association study of obsessive-compulsive disorder. Mol Psychiatry 2013; 18:788-98.
14. Stewart SE, Mayerfeld C, Arnold PD, et al. Meta-analysis of association between obsessive-compulsive disorder and the 3′ region of neuronal glutamate transporter gene SLC1A1. Am J Med Genet B Neuropsychiatr Genet 2013; 162B:367-79.
15. Saxena S, Rauch SL. Functional neuroimaging and the neuroanatomy of obsessive-compulsive disorder. Psychiatr Clin North Am 2000; 23: 563-86.
16. Baxter LR Jr, Phelps ME, Mazziotta JC, Guze BH, Schwartz JM, Selin CE. Local cerebral glucose metabolic rates in obsessive-compulsive disorder: a comparison with rates in unipolar depression and in normal controls. Arch Gen Psychiatry 1987; 44: 211-8.
17. Milad MR, Rauch SL. Obsessive-compulsive disorder: beyond segregated cortico-striatal pathways. Trends Cogn Sci 2012; 16:43-51.
18. Graybiel AM, Rauch SL. Toward a neurobiology of obsessive-compulsive disorder. Neuron 2000; 28:343-7
19. Piras F, Piras F, Caltagirone C, Spalletta G. Brain circuitries of obsessive compulsive disorder: a systematic review and meta-analysis of diffusion tensor imaging studies. Neurosci Biobehav Rev 2013; 37: 2856-77.
20. Menzies L, Achard S, Chamberlain SR, et al. Neurocognitive endophenotypes of obsessive-compulsive disorder. Brain 2007; 130:3223-36.
21. Chamberlain SR, Menzies L, Hampshire A, et al. Orbitofrontal dysfunction in patients with obsessive-compulsive disorder and their unaffected relatives. Science 2008; 321:421-2.
22. Skoog G, Skoog I. A 40-year follow-up of patients with obsessive-compulsive disorder. Arch Gen Psychiatry 1999; 56: 121-7.
23. Mancebo MC, Eisen JL, Pinto A, Greenberg BD, Dyck IR, Rasmussen SA. The Brown Longitudinal Obsessive Compulsive
Study: treatments received and patient impressions of improvement. J Clin Psychiatry 2006; 67:1713-20.
24. Reddy YC, D’Souza SM, Shetti C, et al. An 11- to 13-year follow-up of 75 subjects with obsessive-compulsive disorder. J Clin Psychiatry 2005; 66:744-9.
25. Blanco C, Olfson M, Stein DJ, Simpson HB, Gameroff MJ, Narrow WH. Treatment of obsessive-compulsive disorder by U.S. psychiatrists. J Clin Psychiatry 2006; 67:946-51.
26. Jacob ML, Larson MJ, Storch EA. Insight in adults with obsessive-compulsive disorder. Compr Psychiatry 2014; 55:896-903.
27. Ginsburg GS, Kingery JN, Drake KL, Grados MA. Predictors of treatment response in pediatric obsessive-compulsive disorder. J Am Acad Child Adolesc Psychiatry 2008; 47:868-78.
28. Foa EB. Cognitive behavioral therapy of obsessive-compulsive disorder. Dialogues Clin Neurosci 2010; 12:199-207.
29. Simpson HB, Maher MJ, Wang Y, Bao Y, Foa EB, Franklin M. Patient adherence predicts outcome from cognitive behavioral therapy in obsessive-compulsive disorder. J Consult Clin Psychol 2011; 79:247-
52. 30. Rosa-Alcázar AI, Sánchez-Meca J, Gómez-Conesa A, Marín-Martínez F. Psychological treatment of obsessive-compulsive disorder: a meta-analysis. Clin Psychol Rev 2008; 28:1310-25.
31. Ponniah K, Magiati I, Hollon SD. An update on the efficacy of psychological therapies in the treatment of obsessive compulsive disorder in adults. J Obsessive Compuls Relat Disord 2013; 2:207-18.
32. Lovell K, Cox D, Haddock G, et al. Telephone administered cognitive behavior therapy for treatment of obsessive compulsive disorder: randomized controlled non-inferiority trial. BMJ 2006; 333:883.
33. Greist JH, Marks IM, Baer L, et al. Behavior therapy for obsessive-compulsive disorder guided by a computer or by a clinician compared with relaxation as a control. J Clin Psychiatry 2002; 63:138-45.
34. Andersson E, Enander J, Andrén P, et al. Internet-based cognitive behavior therapy for obsessive-compulsive disorder: a randomized controlled trial. Psychol Med 2012; 42:2193-203.
35. van Oppen P, van Balkom AJ, Smit JH, Schuurmans J, van Dyck R, Emmelkamp PM. Does the therapy manual or the therapist matter most in treatment of obsessive-compulsive disorder? A randomized controlled trial of exposure with response or ritual prevention in 118 patients. J Clin Psychiatry 2010; 71:1158-67.
36. Rachman S, de Silva P. Abnormal and normal obsessions. Behav Res Ther 1978; 16:233-48.
37. Greist JH, Bandelow B, Hollander E, et al. WCA recommendations for the long-term treatment of obsessive-compulsive disorder in adults. CNS Spectr 2003; 8:Suppl 1:7-16.
38. Abramowitz JS. The psychological treatment of obsessive-compulsive disorder. Can J Psychiatry 2006; 51:407-16.
39. Bandelow B, Zohar J, Hollander E, et al. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic stress disorders — first revision. World J Biol Psychiatry 2008; 9:248-312.
40. Soomro GM, Altman D, Rajagopal S, Oakley-Browne M. Selective serotonin reuptake inhibitors (SSRIs) versus placebo for obsessive compulsive disorder (OCD). Cochrane Database Syst Rev 2008; 1: CD001765.
41. Ackerman DL, Greenland S. Multivariate meta-analysis of controlled drug studies for obsessive-compulsive disorder. J Clin Psychopharmacol 2002; 22:309-17.
42. American Psychiatric Association. Practice guidelines for the treatment of patients with obsessive-compulsive disorder. Am J Psychiatry 2007; 164: Suppl: 1-56.
43. Reddy YC, Alur AM, Manjunath S, Kandavel T, Math SB. Long-term follow-up study of patients with serotonin reuptake inhibitor-nonresponsive obsessive-compulsive disorder. J Clin Psychopharmacol 2010; 30:267-72.
44. Ravizza L, Maina G, Bogetto F, Albert U, Barzega G, Bellino S. Long term treatment of obsessive–compulsive disorder.CNS Drugs 1998; 10:247-55.
45. Romanelli RJ, Wu FM, Gamba R, Mojtabai R, Segal JB. Behavioral therapy and serotonin reuptake inhibitor pharmacotherapy in the treatment of obsessive compulsive disorder: a systematic review and meta-analysis of head-to-head randomized controlled trials. Depress Anxiety 2014 January 3 (Epub ahead of print).
46. Bloch MH, Landeros-Weisenberger A, Kelmendi B, Coric V, Bracken MB, Leckman JF. A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder. Mol Psychiatry 2006; 11:622-32.
47. Simpson HB, Foa EB, Liebowitz MR, et al. Cognitive-behavioral therapy vs risperidone for augmenting serotonin reuptake inhibitors in obsessive-compulsive disorder: a randomized clinical trial. JAMA Psychiatry 2013; 70:1190-9.
48. Kordon A, Kahl KG, Broocks A, Voderholzer U, Rasche-Räuchle H, Hohagen F. Clinical outcome in patients with obsessive-compulsive disorder after discontinuation of SRI treatment: results from a two-year follow-up. Eur Arch Psychiatry Clin Neurosci 2005; 255:48-50.
49. Goodman WK, Alterman RL. Deep brain stimulation for intractable psychiatric disorders. Annu Rev Med 2012; 63:511-24.
50. Obsessive-compulsive disorder: core interventions in the treatment of obsessive-compulsive disorder and body dysmorphic disorder. London: National Institute for Health and Clinical Excellence, November 2005 (http://www.nice.org.uk/nicemedia/pdf/cg031niceguideline.pdf).